The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator

Cerebrovascular Diseases
Karine WieglerLorenz Hirt

Abstract

XG-102 (formerly D-JNKI1), a TAT-coupled dextrogyre peptide which selectively inhibits the c-Jun N-terminal kinase, is a powerful neuroprotectant in mouse models of middle cerebral artery occlusion (MCAo) with delayed intracerebroventricular injection. We aimed to determine whether this neuroprotection could also be achieved by intravenous injection of XG-102, which is a more feasible approach for future use in stroke patients. We also tested the compatibility of the compound with recombinant tissue plasminogen activator (rtPA), commonly used for intravenous thrombolysis and known to enhance excitotoxicity. Male ICR-CD1 mice were subjected to a 30-min-suture MCAo. XG-102 was injected intravenously in a single dose, 6 h after ischemia. Hippocampal slice cultures were subjected to oxygen (5%) and glucose (1 mM) deprivation for 30 min. rtPA was added after ischemia and before XG-102 administration, both in vitro and in vivo. The lowest intravenous dose achieving neuroprotection was 0.0003 mg/kg, which reduced the infarct volume after 48 h from 62 +/- 19 mm(3) (n = 18) for the vehicle-treated group to 18 +/- 9 mm(3) (n = 5, p < 0.01). The behavioral outcome was also significantly improved at two doses. Addition of rtPA after ischem...Continue Reading

Citations

Sep 28, 2012·Der Nervenarzt·C Kleinschnitz, N Plesnila
Feb 18, 2011·Genes & Development·Ping XuRoger J Davis
Dec 24, 2010·Cerebrovascular Diseases·Brian Y HwangE Sander Connolly
Aug 21, 2013·International Journal of Molecular Sciences·Osvaldo MiranteLorenz Hirt
May 15, 2015·Journal of Neurotrauma·Susan MarguliesMona Hicks
Nov 12, 2009·Brain, Behavior, and Immunity·Corinne BenakisLorenz Hirt
Aug 26, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·George W J HarstonAlastair M Buchan
Feb 19, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hongxia LeiRolf Gruetter
Oct 6, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·William R GowBruno P Meloni
Aug 14, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Carole BerthetLorenz Hirt
Nov 4, 2015·Frontiers in Cellular Neuroscience·Arnaud ChevilleyDenis Vivien
Sep 2, 2009·Journal of Neurochemistry·Jonathan ThevenetLorenz Hirt
Dec 3, 2008·Journal of Neurochemistry·Vanessa GinetAnita C Truttmann
Oct 19, 2011·Journal of Neurochemistry·Anne VaslinPeter G H Clarke
Jul 11, 2012·International Journal of Cell Biology·Vincent BerezowskiJérôme Badaut
Jun 25, 2013·The International Journal of Biochemistry & Cell Biology·Kevin R W NgoeiMarie A Bogoyevitch
Nov 11, 2009·Biochimica Et Biophysica Acta·Marie A BogoyevitchDominic C H Ng
Apr 18, 2014·Nature Reviews. Neuroscience·Eleanor T Coffey
Feb 11, 2015·Translational Neuroscience·Peng-Fei WangQing-Wu Yang
Jul 10, 2016·Targeted Oncology·Juan Wang, Guixiang Tai
Jul 22, 2018·Frontiers in Pharmacology·Maria ShvedovaDmitriy N Atochin
Nov 22, 2014·Journal of Medicinal Chemistry·Pierre KochStefan A Laufer

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.